참고문헌
- Tucker MA. Melanoma epidemiology. Hematol Oncol Clin North Am 2009;23:383-95. https://doi.org/10.1016/j.hoc.2009.03.010
- Carey WP Jr, Thompson CJ, Synnestvedt M, Guerry D 4th, Halpern A, Schultz D, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 1994;74:3118-25. https://doi.org/10.1002/1097-0142(19941215)74:12<3118::AID-CNCR2820741210>3.0.CO;2-7
- Burden AD, Newell J, Andrew N, Kavanagh G, Connor JM, MacKie RM. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol 1999;135:261-5.
- Masri GD, Clark WH Jr, Guerry D 4th, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990;22(6 Pt 1):1042-8. https://doi.org/10.1016/0190-9622(90)70149-C
- Weinstock MA, Barnhill RL, Rhodes AR, Brodsky GL. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel Arch Dermatol 1997;133:953-8. https://doi.org/10.1001/archderm.1997.03890440019002
- Bergman W, van Voorst Vader PC, Ruiter DJ. Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra. Ned Tijdschr Geneeskd 1997;141:2010-4.
- Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: I. common and atypical naevi. Eur J Cancer 2005;41:28-44. https://doi.org/10.1016/j.ejca.2004.10.015
- Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, et al. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 2002;94:3192-209. https://doi.org/10.1002/cncr.10605
- Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995;33:1000-7. https://doi.org/10.1016/0190-9622(95)90294-5
- Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H. Cutaneous melanomas associated with nevi. Arch Dermatol 2003;139:1620-4. https://doi.org/10.1001/archderm.139.12.1620
- Goodson AG, Florell SR, Boucher KM, Grossman D. A decade of melanomas: identification of factors associated with delayed detection in an academic group practice. Dermatol Surg 2011;37:1620-30. https://doi.org/10.1111/j.1524-4725.2011.02097.x
- Kim CC, Swetter SM, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, et al. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. JAMA Dermatol 2015;151:212-8. https://doi.org/10.1001/jamadermatol.2014.2694
- Schoenfeld RJ, Pinkus H. The recurrence of nevi after incomplete removal. AMA Arch Derm 1958;78:30-5. https://doi.org/10.1001/archderm.1958.01560070032004
- King R, Hayzen BA, Page RN, Googe PB, Zeagler D, Mihm MC Jr. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol 2009;22:611-7. https://doi.org/10.1038/modpathol.2009.22
- Blum A, Hofmann-Wellenhof R, Marghoob AA, Argenziano G, Cabo H, Carrera C, et al. Recurrent melanocytic nevi and melanmas in dermoscopy: results of a multicenter study of the International Dermoscopy Society. JAMA Dermatol 2014;150:138-45. https://doi.org/10.1001/jamadermatol.2013.6908